0001235802-23-000003.txt : 20230103 0001235802-23-000003.hdr.sgml : 20230103 20230103163627 ACCESSION NUMBER: 0001235802-23-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burroughs Amy L. CENTRAL INDEX KEY: 0001872564 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 23502691 MAIL ADDRESS: STREET 1: TWO CARLSON PARKWAY, SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-01-03 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001872564 Burroughs Amy L. 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305 1 0 0 0 Voting Common Shares, no par value per share 2023-01-03 4 A 0 17156 1.53 A 73288 D These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $26,250. Includes 28,338 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan. /s/ Amy Culbert, attorney-in-fact 2023-01-03